Clinical Trials Directory

Trials / Completed

CompletedNCT04885296

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
228 (actual)
Sponsor
Johnson & Johnson Vision Care, Inc. · Industry
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

This is a bilateral, 2-week dispensing, randomized, controlled, subject-masked, 2×2 crossover study to evaluate the clinical performance of prototype contact lenses with experimental UV/HEV-blocker.

Conditions

Interventions

TypeNameDescription
DEVICETRP-200JJVC Investigational Contact Lens
DEVICEJJVC Marketed Contact LensACUVUE Oasys 1-Day

Timeline

Start date
2021-05-10
Primary completion
2021-08-09
Completion
2021-08-09
First posted
2021-05-13
Last updated
2022-09-01
Results posted
2022-09-01

Locations

12 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04885296. Inclusion in this directory is not an endorsement.

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker (NCT04885296) · Clinical Trials Directory